Also known as ISMMS Endowment
Icahn School of Medicine at Mount Sinai Endowment's investment portfolio is valued at $674.04 million as of December 31, 2022, with investments in private equity, real estate, hedge funds, real assets, natural resources, and cash. As of December 31, 2022, the private equity portfolio was valued at $17.89 million, representing 2.7% of the total portfolio. Investments in private equity include buyouts, diversified private equity, private equity growth expansion, and venture capital strategies. The endowment's investments are governed by the executive management team, with Mr. Scott Pittman serving as Chief Investment Officer & Senior Vice President.
Browse more endowment plans and other institutional investors by location and type in the LPbacked limited-partner database.
Mount Sinai Medical Center Endowment is a endowment plan based in New York, United States, managing approximately $675M in assets.
Mount Sinai Medical Center Endowment is headquartered in New York, United States.
Mount Sinai Medical Center Endowment manages approximately $675M in assets under management.
Mount Sinai Medical Center Endowment focuses on Buyout, Private Equity, Growth/Expansion, Hedge Fund, Real Assets & Natural Resources - General, Real Estate - General, Venture Capital, Venture Capital - Early Stage.
Verified contact details, key decision-makers, and investment preferences for Mount Sinai Medical Center Endowment are available on LPbacked. Create a free account to access them.